Skip to content

Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty

Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty: a Randomized Controlled Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01857011
Acronym
ISAPA
Enrollment
56
Registered
2013-05-20
Start date
2014-04-30
Completion date
2016-06-30
Last updated
2017-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Iron-Deficiency, Weight Loss

Keywords

Anemia, Iron-Deficiency, bariatric surgery, abdominoplasty, surgery, plastic, iron

Brief summary

The purpose of this study is to determine whether intravenous or oral iron are effective in the treatment of postoperative anemia and iron deficiency in patients submitted in postbariatric abdominoplasty.

Detailed description

Multicenter open randomized clinical trial with allocation ratio 1: 1. 56 adult patients undergoing post- bariatric abdominoplasty will be evaluated. The study group will receive 200 mg of intravenous iron in the immediate postoperative period and a second application on day 1 postoperatively. The control group will receive 100 mg of oral iron twice daily for 8 weeks. Haematological variables , iron 's profile , quality of life ( SF -36 and FACT- An) and adverse events will be assessed preoperatively and on the first , fourth and eighth weeks postoperatively .

Interventions

Intravenous Iron Sucrose 200 mg in the immediate postoperative period and first day postop.

Oral iron(III)-hydroxide polymaltose complex 100 mg twice daily in the fist 8 postoperative weeks.

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Women * 18 a 55 years * Prior open or laparoscopic standard limb Roux and Y gastric bypass * BMI \< 32 kg/m2 * Stability of weight loss for at least 6 months * grade 3 abdominal deformity on the Pittsburgh scale

Exclusion criteria

* Illiterate * Current smoking * Prior IV iron use in the last 3 months * Uncontrolled systemic diseases * Hemoglobin \< 11 g/dL * Ferritin \<11 ng/mL * Ferritin \> 100 ng/mL * transferrin saturation \<16% * transferrin saturation\> 50% * B12 \< 210 pg/mL * Folic Acid \< 3.3 ng/mL * Albumin \< 2 g/dL * C reactive protein\> 5 mg/L * Prior Anaphylactic reaction to IV iron

Design outcomes

Primary

MeasureTime frameDescription
Hemoglobin level8 postoperative weeksHemoglobin level measured at 8 postoperative weeks

Secondary

MeasureTime frameDescription
Ferritin levelsPreoperative (one day before surgery) and 1, 4 and 8 postoperative weeks
FACITPreoperative (one day before surgery) and 1, 4 and 8 postoperative weeksThe FACIT Fatigue Scale is a health related quality of life (HRQOL) questionnaire targeted to evaluate fatigue.
SF36Preoperative (one day before surgery) and 1, 4 and 8 postoperative weeksQuality of Life Questionnaire
Transferrin saturationPreoperative (one day before surgery) and 1, 4 and 8 postoperative weeks
Hemoglobin levelspreoperative (one day before surgery) and 1, 4 postoperative weeks

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026